Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14639966 | 1.00 | THRB (0.38) | THRBLMNA | |
| SCHEMBL21967082 | 0.85 | THRB (0.32) | THRBLMNA | |
| SCHEMBL4227890 | 0.85 | THRB (0.32) | THRBLMNA | |
| SCHEMBL21670643 | 0.85 | THRB (0.32) | THRBLMNA | |
| SCHEMBL3504051 | 0.85 | THRB (0.32) | THRBLMNA | |
| SCHEMBL21670606 | 0.85 | THRB (0.32) | THRBLMNA | |
| SCHEMBL8664988 | 0.82 | THRB (0.47) | THRBLMNA | |
| SCHEMBL6258854 | 0.79 | THRB (0.35) | THRBLMNA | |
| SCHEMBL12402920 | 0.79 | THRB (0.35) | THRBLMNA | |
| SCHEMBL872769 | 0.79 | THRB (0.35) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1738811-A | Method for preparing 1-acetoxyl-3- (substituted phenyl) propylene compound | UBE INDUSTRIES (JP) | 2006-02-22 | — | — | CN | claimed |
| CN-101896492-B | Tetriacyclodipyranyl coumarins and the anti-HIV and anti-tuberculosis uses thereof | INST OF MATARIA MEDICA CHINESE | 2015-05-06 | — | — | CN | disclosed |
| EP-2216335-B1 | TETRACYCLODIPYRANYL COUMARINS AND THE ANTI-HIV AND ANTI-TUBERCULOSIS USES THEREOF | INST MATERIA MEDICA CAMS (CN) | 2014-03-12 | — | — | EP | disclosed |
| CN-101100470-B | Tetracyclic bispyranyl coumarin compounds | INST MATERIA MEDICA CAMS | 2013-02-13 | — | — | CN | disclosed |
| US-20100324067-A1 | TETRACYCLIC DIPYRANO-COUMARIN COMPOUNDS WITH ANTI-HIV AND ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITIES | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2010-12-23 | — | — | US | disclosed |
| CN-101896492-A | Tetriacyclodipyranyl coumarins and the anti-HIV and anti-tuberculosis uses thereof | INST OF MATARIA MEDICA CHINESE | 2010-11-24 | — | — | CN | disclosed |
| EP-2216335-A1 | TETRIACYCLODIPYRANYL COUMARINS AND THE ANTI-HIV AND ANTI-TUBERCULOSIS USES THEREOF | Institute of Mataria Medica, Chinese Academy of Medical Sciences (CN) | 2010-08-11 | — | — | EP | disclosed |
| CN-100415734-C | 1-acetoxy-3- (substituted phenyl) propen compounds | UBE INDUSTRIES (JP) | 2008-09-03 | — | — | CN | disclosed |
| CN-101100470-A | Tetracyclic bispyranyl coumarin compounds | INST MATERIA MEDICA CAMS (CN) | 2008-01-09 | — | — | CN | disclosed |
| CN-1807423-A | 1-acetoxy-3- (substituted phenyl) propen compounds | UBE INDUSTRIES (JP) | 2006-07-26 | — | — | CN | disclosed |
| CN-1738811-A | Method for preparing 1-acetoxyl-3- (substituted phenyl) propylene compound | UBE INDUSTRIES (JP) | 2006-02-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324067-A1 | TETRACYCLIC DIPYRANO-COUMARIN COMPOUNDS WITH ANTI-HIV AND ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITIES | TBCB, TBC1D15, TBC1D5 | THRB 1864/4885LMNA 2668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.